Loading…
Atomelody (深旋科技, Shenxuan Keji) is an AI-driven macromolecule drug discovery company founded in 2026 and based in the Nanshan district of Shenzhen, China. It builds all-atom foundation models spanning proteins, antibodies, peptides and minibinders, nucleic acids and small molecules, and pairs them with a protein design system and a developability optimisation pipeline aimed at cyclic peptide and nanobody discovery against difficult targets.
All-atom diffusion model for joint protein, peptide, nucleic acid and ligand complex prediction, scored on interface accuracy and steric validity.